Volume | 200 108 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 13,43 | Bas Haut |
|||||
Minimum Bas | 11,57 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Cidara Therapeutics Inc | CDTX | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
12,65 | 11,57 | 13,43 | 12,63 | 13,00 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
2 812 | 200 108 | US$ 12,79 | US$ 2 560 204 | - | 10,004 - 29,60 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:58:56 | 8 | US$ 12,53 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
1,14B | 90,43M | - | 64,29M | -29,8M | -0,33 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Cidara Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
04/3/2024 | 22:22 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
23/2/2024 | 22:05 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
09/2/2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
22/12/2023 | 13:33 | Edgar (US Regulatory) | Form 8-K - Current report |
17/11/2023 | 19:22 | Edgar (US Regulatory) | Form 8-K - Current report |
16/11/2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
02/11/2023 | 21:08 | Edgar (US Regulatory) | Form 8-K - Current report |
02/11/2023 | 21:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/10/2023 | 16:36 | Edgar (US Regulatory) | Form 8-K - Current report |
21/9/2023 | 19:24 | Edgar (US Regulatory) | Form 8-K - Current report |
13/9/2023 | 22:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
13/9/2023 | 22:22 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Action Cidara Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Cidara Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 14,10 | 14,96 | 10,004 | 10,80 | 1 405 907 | -1,40 | -9,93% |
1 mois | 16,20 | 24,40 | 10,004 | 16,92 | 1 200 095 | -3,50 | -21,60% |
3 mois | 13,198 | 24,40 | 10,004 | 15,84 | 744 906 | -0,498 | -3,77% |
6 mois | 17,00 | 24,40 | 10,004 | 15,58 | 681 524 | -4,30 | -25,29% |
1 an | 20,60 | 29,60 | 10,004 | 18,74 | 673 530 | -7,90 | -38,35% |
3 ans | 44,20 | 47,80 | 8,00 | 24,59 | 806 250 | -31,50 | -71,27% |
5 ans | 45,60 | 89,00 | 8,00 | 31,54 | 637 543 | -32,90 | -72,15% |